School of Medicine
Showing 21-30 of 41 Results
-
Keith Humphreys
Esther Ting Memorial Professor and Professor, by courtesy, of Health Policy
Current Research and Scholarly InterestsDr. Humphreys researches individual and societal level interventions for addictive and psychiatric disorders. He focuses particularly on evaluating the outcomes of professionally-administered treatments and peer-operated self-help groups (e.g., Alcoholics Anonymous), and, analyzing the impact of public policies touching addiction, mental health, public health, and public safety.
-
Michelle Mello
Professor of Law and of Health Policy
BioMichelle Mello is Professor of Law at Stanford Law School and Professor of Health Policy in the Department of Health Policy at Stanford University School of Medicine. She conducts empirical research into issues at the intersection of law, ethics, and health policy. She is the author of more than 250 articles on medical liability, public health law, the public health response to COVID-19, pharmaceuticals and vaccines, biomedical research ethics and governance, artificial intelligence, health information privacy, and other topics.
The recipient of a number of awards for her research, Dr. Mello was elected to the National Academy of Medicine at the age of 40. From 2000 to 2014, she was a professor at the Harvard School of Public Health, where she directed the School’s Program in Law and Public Health.
Dr. Mello teaches courses in torts and public health law. She holds a J.D. from the Yale Law School, a Ph.D. in Health Policy and Administration from the University of North Carolina at Chapel Hill, an M.Phil. from Oxford University, where she was a Marshall Scholar, and a B.A. from Stanford University. -
Arden Morris, MD, MPH, FACS
Robert L. and Mary Ellenburg Professor of Surgery, and Professor, by courtesy, of Health Policy
BioArden M. Morris, MD, MPH is Vice-Chair for Clinical Research, the Robert L. and Mary Ellenburg Professor of Surgery, and by courtesy Professor of Health Policy at the Stanford School of Medicine. She is Director of the S-SPIRE Center, a health services research collaborative to study patient-centered care, clinical optimization, and health care economics. In her own work, Dr. Morris uses quantitative, qualitative, and mixed research methods to focus on quality of and equity in cancer care. To that end, she currently is funded by American Cancer Society and NIH to study access to care, clinical outcomes, and policy related to insurance design. Dr. Morris currently serves on the American Joint Commission on Cancer, the NIH Special Emphasis Panel “Topics in Health Services Research: Big Data, Health Information Technology, and Clinical Informatics,” and as Associate Editor for Surgery at JAMA Network Open.
-
Doug Owens
Henry J. Kaiser, Jr. Professor, Senior Fellow at the Freeman Spogli Institute for International Studies and Professor, by courtesy, of Management Science and Engineering
Current Research and Scholarly InterestsMy research uses decision modeling, cost-effectiveness analysis, and meta-analysis to evaluate clinical and health policy problems. Much of my work involves development of national guidelines for prevention and treatment.
-
Petra Persson
Associate Professor of Economics, Senior Fellow at the Stanford Institute for Economic Policy Research and Associate Professor, by courtesy, of Health Policy
BioPetra Persson is Associate Professor of Economics at Stanford University, where she also serves as the Nina C. Crocker Faculty Scholar in the School of Humanities and Sciences and holds a courtesy appointment as Associate Professor of Health Policy. She is a Faculty Research Associate at the National Bureau of Economic Research, a Senior Fellow at the Stanford Institute for Economic Policy Research, and a Research Affiliate at the Centre for Economic Policy Research.
Professor Persson earned her PhD in Economics from Columbia University in 2013, her MSc in Economics from Stockholm School of Economics in 2006, and her BA in Political Science and Mathematics from Stockholm University in 2005. Prior to joining the Stanford faculty, she was a Postdoctoral Fellow at the Stanford Institute for Economic Policy Research (2013-2014) and a Dissertation Fellow at the Harvard Kennedy School Women and Public Policy Program (2012-2013).
Persson's research lies at the intersection of family economics, health economics, and public finance, spanning topics including health disparities, maternal and child well-being, family structure and behavior, fertility policy, and social insurance design. She is the recipient of the National Science Foundation CAREER Award and has published articles in leading peer-reviewed journals, including the American Economic Review, Journal of Political Economy, American Economic Review: Insights, American Economic Journal: Applied Economics, American Economic Journal: Economic Policy, and British Medical Journal. -
David Rehkopf
Professor of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Pediatrics, of Health Policy and of Sociology
BioI am a social epidemiologist and serve as a Professor in the Department of Epidemiology and Population Health and in the Department of Medicine in the Division of Primary Care and Population Health. I joined the faculty at Stanford School of Medicine in 2011.
I am Director of the Stanford Center for Population Health Sciences. In this position, I am committed to making high-value data resources available to researchers across disciplines in order to better enable them to answer their most pressing clinical and population health questions.
My own research is focused on understanding the health implications of the myriad decisions that are made by corporations and governments every day - decisions that profoundly shape the social and economic worlds in which we live and work. While these changes are often invisible to us on a daily basis, these seemingly minor actions and decisions form structural nudges that can create better or worse health at a population level. My work demonstrates the health implications of corporate and governmental decisions that can give the public and policy makers evidence to support new strategies for promoting health and well-being. In all of his work, I have a focus on the implications of these exposures for health inequalities.
Since often policy and programmatic changes can take decades to influence health, my work also includes more basic research in understanding biological signals that may act as early warning signs of systemic disease, in particular accelerated aging. I examine how social and economic policy changes influence a range of early markers of disease and aging, with a particular recent focus on DNA methylation. I am supported by several grants from the National Institute on Aging and the National Institute on Minority Health and Health Disparities to develop new more sensitive ways to understand the health implications of social and economic policy changes.
